Nulojix 250 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Swissmedic Key 61521003 PP Registration Holder Bristol-Myers Squibb SA Name Nulojix 250 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Date of registration 15.12.2011 Introduction of Sequence 15.12.2011 ATC-Classification Belatacept (L04AA28) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.15. Show package size Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 391.50 Limitation Yes Limitation text
Deductible 10 % Consumer price 442.20 Feedback FB GTIN 7680615210037 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: belataceptum 250 mg, saccharum, natrii dihydrogenophosphas monohydricus, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium max. 13 mg. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Excipiens BAG: Active Agent Dose 250 mg
Inactive agents Sodium Chloride Sodium Dihydrogenophosphate Monohydrate Sodium Hydroxide Saccharum
Source Data was imported : 12.01.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
